Powered by: Motilal Oswal
2026-07-30 11:54:06 am | Source: Emkay Global Financial Services
Buy Coforge Ltd for the Target Rs1,800 by Emkay Global Financial Services Ltd
Buy Coforge Ltd for the Target Rs1,800 by Emkay Global Financial Services Ltd

Coforge posted healthy operating performance in 1Q. Revenue grew 21.1% qoq to $592.2mn (22.3% CC; organic: 1.1% CC), largely in line with our estimate of 22.4% CC. EBITM contracted by 60bps qoq to 16%, higher than our estimate of 15.7%. Coforge signed 4 large deals in 1Q, with total order intake of $691mn (excluding order intake from Encora and UK framework agreement deal), lifting the next 12M executable orderbook to $2.23bn. It sees large deal signing momentum gaining strength in 2Q, expecting the number of deals signed to be close to that in full-year FY23 (11), with most of these translating to revenue from 3Q. Approximately 6-7% of revenue comes from outcome-based contracts, and 30% of active delivery projects are driven by AI assets. The company expects a) industry-leading revenue growth and margin in FY27; b) EBITDAM/EBITM (including Encora) to sustain at 20.5-21%/15.5% in FY27; c) FCF/PAT of >100%; and d) EPS accretion from Encora integration in FY27 (on track). We tweak FY27-29E EPS by -1.0% to 3.3%, factoring in 1Q performance and management outlook on deals and growth. We retain BUY and raise TP by ~6% to Rs1,800 (from Rs1,700), at 24x Jun-28E EPS.

Results summary

Revenue grew 21.1% qoq to $592.2mn (22.3% CC; organic: 1.1% CC). Adjusted for the planned exit from low-margin India government business ($15mn) and divestment of a data center asset ($4mn), organic revenue growth stood at 5.2% qoq in CC terms. EBITM declined by 60bps qoq to 16%, above our estimate of 15.7%. Net profit stood at Rs5.2bn, tad above our estimate. Total headcount rose ~10.5k to 46,228 (including 9,256 from Encora). Coforge declared interim dividend of Rs4/share. What we like: Strong execution, margin beat, strong deal intake. What we do not like: cash conversion.

Encora acquisition on track to be EPS-accretive in FY27

The company consolidated 2 months of Encora’s financials post-acquisition (~$100.7mn revenue contribution) in 1Q. Per the management, the integration is ahead of schedule, with all 45 legal entities migrated to SAP S/4HANA. Early synergies are visible across AIled engineering, Hi-tech and Healthcare expansion, and cross-selling. Client mining remains strong: one former Encora client entered the top-10 accounts and is expected to exceed $50mn in revenue over the next 12–18M; two more clients are expected to scale through cross-selling. AI-led engineering, data, and cloud services contribute ~86% to revenue (vs initial 80% target). Encora delivered EBITDAM/EBITM of ~20.3/19.1%, respectively, in 1Q, while G&A costs declined ~40%, with further synergies expected from 2Q. Acquisition-related expenses stood at $6.5mn in 1Q (vs $5.4mn in 4Q), with total integration costs expected to remain within the $15mn guided budget

Recently won large deals in ramp-up phase

The management indicated that the $158mn transformation deal is fully ramped up and contributing at the planned run rate. The $230mn AI-led digital transformation deal entered the ramp-up phase in 2Q, and is expected to contribute progressively over the coming quarters as delivery scales and implementation advances.

 

For More  Emkay Global Financial Services Ltd Disclaimer http://www.emkayglobal.com/Uploads/disclaimer.pdf & SEBI Registration number is INH000000354

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here